Hafner Group, a Germany-based specialist in nutraceutical manufacturing, has announced a significant strategic collaboration through the signing of a Memorandum of Understanding (MOU) with Vibhavadi Hospital. This partnership is dedicated to the co-development of nutraceutical products within a tangible “Prevention” framework, with the shared objective of enhancing long-term health outcomes and elevating the quality of preventive healthcare for the Thai population.
This alliance marks a pivotal milestone for both organizations, integrating clinical medical expertise with world-class innovation under a unified vision: the creation of the “Real Keys of Healthspan” a pathway toward sustainable, lifelong well-being.
Ms. Supaporn Häfner, Chief Executive Officer of Hafner Group Co., Ltd., articulated the strategic intent behind this collaboration: “At the core of this partnership lies the development of Made-in-Germany nutraceuticals in the form of Medical Nutraceuticals capable of delivering measurable outcomes in preventive health. Hafner Group leverages advanced delivery technologies, including Liposomal systems, which enhance absorption in both aqueous and lipid environments, and Nano Encapsulation, which enables precise, targeted delivery of active compounds. These innovations are designed to extend the healthspan of the Thai population. Our ambition is to position these products not merely as supplements, but as essential instruments for designing a proactive health-oriented lifestyle reflecting our commitment to enhancing quality of life through to its very final stages.”
Ms. Nutcha Kitjariyapoom, Chief Strategic Advisor for Nutraceutical Innovation Products at Vibhavadi Hospital, further emphasized: “Guided by the principle of the ‘Power of Prevention,’ Vibhavadi Hospital is committed to advancing a proactive healthcare model. Our collaboration with Hafner Group aims to develop nutraceutical solutions that support both patients and the general public from the comfort of their homes prior to the need for clinical intervention. We are determined to deliver products that are safe, efficacious, evidence-based, and tailored to individual needs, while elevating the standards of Thailand’s nutraceutical industry into a truly trusted healthcare alternative.”
The nutraceutical products developed under the Vibhavadi brand manufactured to world-class German standards will be grounded in robust medical knowledge and supported by scientific research, ensuring both efficacy and safety for long-term, continuous consumption.
Together, both organizations are championing a comprehensive healthcare paradigm encapsulated in the principles of “disease prevention, degeneration delay, and therapeutic enhancement.” These products are designed to support both self-care at home and integrative use alongside hospital-based treatments, forming a seamless and holistic healthcare ecosystem.
This collaboration between Hafner Group and Vibhavadi Hospital represents not only a strategic business advancement, but also a foundational step in operationalizing the concept of “Prevention” within Thailand. It lays the groundwork for a future in which sustainable health and extended healthspan become attainable realities for all.